EUVIMEDEUVIMED entdecken
Übersichtsarbeit

LRRK2 Inhibitors as Promising Treatment for Parkinson’s Disease

Shuoyan Tan, Huanxiang Liu iD, Xiaojun Yao iD

ACS Chemical Neuroscience · 2024

DOI: 10.1021/acschemneuro.4c00657 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Shuoyan Tan und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Parkinson Disease, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Protein Kinase Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Protein Kinase InhibitorsHumansAnimalsAntiparkinson Agents

Stichwörter der Autor:innen

Leucine-rich repeat kinase 2Parkinson’s diseasekinase inhibitor

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Protein Kinase InhibitorsLRRK2 protein, humanAntiparkinson Agents

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • State Key Laboratory of Chinese Medicine Modernization, Innovation Center of Yangtze River Delta, Zhejiang University, Jiaxing 314100, China.
  • Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China.

ORCID-Profile: Huanxiang Liu, Xiaojun Yao

Förderung

  • Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia

Zitieren

APA

Tan, S., Liu, H., & Yao, X. (2024). LRRK2 Inhibitors as Promising Treatment for Parkinson’s Disease. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00657

Vancouver

Tan S, Liu H, Yao X. LRRK2 Inhibitors as Promising Treatment for Parkinson’s Disease. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.4c00657

BibTeX
@article{Tan2024,
  author = {Tan, Shuoyan and Liu, Huanxiang and Yao, Xiaojun},
  title = {LRRK2 Inhibitors as Promising Treatment for Parkinson’s Disease},
  journal = {ACS Chemical Neuroscience},
  year = {2024},
  doi = {10.1021/acschemneuro.4c00657}
}
Kostenlos starten →